These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9097983)

  • 1. Increase in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 gene.
    Matsumura Y; Yamagishi N; Miyakoshi J; Imamura S; Takebe H
    Cancer Lett; 1997 May; 115(1):91-6. PubMed ID: 9097983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased radiosensitivity of p16 gene-deleted human glioma cells after transfection with wild-type p16 gene.
    Miyakoshi J; Kitagawa K; Yamagishi N; Ohtsu S; Day RS; Takebe H
    Jpn J Cancer Res; 1997 Jan; 88(1):34-8. PubMed ID: 9045893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CDKN2A/p16 is inactivated in most melanoma cell lines.
    Castellano M; Pollock PM; Walters MK; Sparrow LE; Down LM; Gabrielli BG; Parsons PG; Hayward NK
    Cancer Res; 1997 Nov; 57(21):4868-75. PubMed ID: 9354451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of the oncogenes NRAS and MYC on the radiation sensitivity of cells of a human melanoma cell line.
    Pomp J; Ouwerkerk IJ; Hermans J; Wondergem J; Cornelisse CJ; Leer JW; Schrier PI
    Radiat Res; 1996 Oct; 146(4):374-81. PubMed ID: 8927709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the cyclin-dependent kinase inhibitors p16 and p21 in the human melanocytic system.
    Wang Y; Becker D
    Oncogene; 1996 Mar; 12(5):1069-75. PubMed ID: 8649798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased radiosensitivity with chronic hypoxia in four human tumor cell lines.
    Zölzer F; Streffer C
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):910-20. PubMed ID: 12377345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K; Feisthammel J; Klee K; Tannapfel A; Witzigmann H; Wittekind C; Mössner J; Berr F
    Int J Cancer; 2002 Feb; 97(4):481-8. PubMed ID: 11802210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel germline p16 mutation in familial malignant melanoma in southern Sweden.
    Borg A; Johannsson U; Johannsson O; Häkansson S; Westerdahl J; Mäsbäck A; Olsson H; Ingvar C
    Cancer Res; 1996 Jun; 56(11):2497-500. PubMed ID: 8653684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines.
    Servomaa K; Kiuru A; Grénman R; Pekkola-Heino K; Pulkkinen JO; Rytömaa T
    Cell Prolif; 1996 May; 29(5):219-30. PubMed ID: 8782485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors.
    Gonzalgo ML; Bender CM; You EH; Glendening JM; Flores JF; Walker GJ; Hayward NK; Jones PA; Fountain JW
    Cancer Res; 1997 Dec; 57(23):5336-47. PubMed ID: 9393758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial head and neck cancer: molecular analysis of a new clinical entity.
    Yu KK; Zanation AM; Moss JR; Yarbrough WG
    Laryngoscope; 2002 Sep; 112(9):1587-93. PubMed ID: 12352668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p16 gene alterations in nasopharyngeal carcinoma.
    Lo KW; Huang DP; Lau KM
    Cancer Res; 1995 May; 55(10):2039-43. PubMed ID: 7743498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of p16CDKN2A in cell cycle delays after low dose UV irradiation.
    Milligan A; Gabrielli BG; Clark JM; Hayward NK; Ellem KA
    Mutat Res; 1998 Nov; 422(1):43-53. PubMed ID: 9920427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro study examining the effect of sub-lethal QS 755 nm lasers on the expression of p16INK4a on melanoma cell lines.
    Chan HH; Xiang L; Leung JC; Tsang KW; Lai KN
    Lasers Surg Med; 2003; 32(2):88-93. PubMed ID: 12561040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Germline p16 mutations in familial melanoma.
    Hussussian CJ; Struewing JP; Goldstein AM; Higgins PA; Ally DS; Sheahan MD; Clark WH; Tucker MA; Dracopoli NC
    Nat Genet; 1994 Sep; 8(1):15-21. PubMed ID: 7987387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of dominant negative CREB reduces resistance to radiation of human melanoma cells.
    Yang YM; Dolan LR; Ronai Z
    Oncogene; 1996 May; 12(10):2223-33. PubMed ID: 8668349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of the p16 gene is related to increased radiosensitivity of p16-deficient lung adenocarcinoma cell lines.
    Fu XY; Zhang SW; Ran RQ; Shen ZH; Gu JX; Cao SL
    J Cancer Res Clin Oncol; 1998; 124(11):621-6. PubMed ID: 9860291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p16/CDKN2 and CDK4 gene mutations in sporadic melanoma development and progression.
    Piccinin S; Doglioni C; Maestro R; Vukosavljevic T; Gasparotto D; D'Orazi C; Boiocchi M
    Int J Cancer; 1997 Feb; 74(1):26-30. PubMed ID: 9036865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiosensitivity of human prostate cancer and malignant melanoma cell lines.
    Wollin M; FitzGerald TJ; Santucci MA; Menon M; Longcope C; Reale F; Carlson J; Sakakeeny MA; Greenberger JS
    Radiother Oncol; 1989 Jul; 15(3):285-93. PubMed ID: 2772256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families.
    Yakobson E; Shemesh P; Azizi E; Winkler E; Lassam N; Hogg D; Brookes S; Peters G; Lotem M; Zlotogorski A; Landau M; Safro M; Shafir R; Friedman E; Peretz H
    Eur J Hum Genet; 2000 Aug; 8(8):590-6. PubMed ID: 10951521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.